Active Sites Display

WP_027099475.1:PROKKA_00293
Sequence length: 1170 aa
5 domain hit(s)
This protein was scanned against CAZyme family profile alignments to identify conserved domains. Each hit below shows a region of the query that aligns to a known CAZyme family. Within each family profile, certain residues are known or predicted to be catalytic — directly involved in the enzyme's chemical reaction. The sequence display compares these critical positions between the query protein and the family consensus:
Match: the query has the expected catalytic residue, suggesting this active site is conserved and likely functional.
Mismatch: the query has a different residue at this position, which may indicate altered activity, a non-functional site, or subfamily variation.
Gap: the catalytic position in the profile has no corresponding residue in the query alignment, suggesting a deletion or truncation in this region.
Match
Mismatch
Gap
Active Site Conservation Analysis
EntryClassNameDomain RangeCoverageConservationCat. SitesMatches
IPR002889CBMCarbohydrate-binding WSC1–117087%57.9%159
PF03442CBMCarbohydrate binding domain X21–115179.8%42.4%167
IPR001329GHGlycoside hydrolase family 56, bee venom hyaluronidase11–24100%60%31
IPR006101GHGlycoside hydrolase, family 2283–298100%57.1%21
PF03633GHGlycosyl hydrolase family 65, C-terminal domain1–99870.8%66.7%00
Domain coverage (1–1170 aa)
IPR002889 — Carbohydrate-binding WSC (domain 1–1170)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MRKMKTMDGN TAAAHISYAF TEVAAIYPIT PSSPMAEHVD EWVAQGRKNI FGQPVQVMEM QSEAGAAGAV HGSLQAGALT STYTASQGLL LMIPNMYKIA GEMLPGVFHV SARALATSAL NIFGDHQDVM AARQTGFAML AEGSVQEVMD LSAVAHLTAI KSRIPFVNFF DGFRTSHEIQ KIEVLEYDEL ANLVDWDSVE AFRARALNPN HPVTRGTAQN ADIYFQEREA VNKFYQAVPD IVEGYMAEIT KLTGREYHCF DYYGAPDADR IIIAMGSVTD VCEETVDYLN ANGQKVGVVK VRLYRPFSIE KLMKAIPASA KKIAVLDRTK EPGSAGEPLY LDVKNAFYGK ENAPVIVGGR FGLGSKDPNP GHIAAVYENL AKEDSKDGFT IGIVDDVTNT SLEVHQDIDA TPEGTTACKF WGLGSDGTVG ANKSAIKIIG DHTDMYAQGY FFYDSKKSGG ITVSHLRFGK KAIKSPYLIN KADFVSCSNQ SYVHKYNVLD GLKPGSTFLL NTIWTPEELE EKLPGSYKRF LANNNIKFYT INAVGIAQEI GLGGRINMIM QSAFFKLANI IPVEDAVKYL KDAVVTSYGK KGQKVVDMNN AAIDKGVESI VKIDIPESWK DAKDEEVENN HKMTEFVKNI VIPMNRQEGD SLPVSTFMGM EDGTFEAGTA AYEKRGIAVN VPEWVPEKCI QCNQCAYVCP HAAIRPFLLN DAEKAAAPES MKLVPAKALK TEEPLSFSIG VTPLDCTGCG NCAQVCPAPG KALIMKPQES QHDQMEAWDY AVEEVSAKKN PMNKNTVKGS QFEQPLLEFS GACAGCGETP YAKLITQLFG DRMMIANATG CSSIWGGSAP STPYTINHKG HGPAWANSLF EDNAEFGLGM FLGVKAIRER IANNLKALLE EGVNDDVKVV VEDWLANMNN GEGTRDRAEK LEATLATVNS ELAKKVLDEK DYFVKRSQWI FGGDGWAYDI GYGGVDHVLA SGEDVNIFVF DTEVYSNTGG QSSKSTPTAA IAKFAASGKK TKKKDLGMMA MSYGYVYVAQ VNMGADKNQT LKAIAEAEAY QGPSLIIGYA PCINHGIKIG MGNSQQEAKR ATDCGYWAMY RYNPQLKGTK NPFALDSKEP KADFKEFLMG EVRYASLAKA FPEAADALFE KTYNDAMERL AGYKKLAEQE Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······C·N· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ····C····· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··C··C···· ·········· ·········· CR········ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·C········ ·T········ ···C·····Y ···R······ ·········· ·········· ·········· ·········· ·········· ·········D
query > profilegap>C7C487>C35N489>N37C695>C40C813>C57C816>C59C841>C77S842>R78C1072>C82G1082>T92C1094>C93Y1100>Y102P1104>R106E1170>D107gap>R108
PF03442 — Carbohydrate binding domain X2 (domain 1–1151)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MRKMKTMDGN TAAAHISYAF TEVAAIYPIT PSSPMAEHVD EWVAQGRKNI FGQPVQVMEM QSEAGAAGAV HGSLQAGALT STYTASQGLL LMIPNMYKIA GEMLPGVFHV SARALATSAL NIFGDHQDVM AARQTGFAML AEGSVQEVMD LSAVAHLTAI KSRIPFVNFF DGFRTSHEIQ KIEVLEYDEL ANLVDWDSVE AFRARALNPN HPVTRGTAQN ADIYFQEREA VNKFYQAVPD IVEGYMAEIT KLTGREYHCF DYYGAPDADR IIIAMGSVTD VCEETVDYLN ANGQKVGVVK VRLYRPFSIE KLMKAIPASA KKIAVLDRTK EPGSAGEPLY LDVKNAFYGK ENAPVIVGGR FGLGSKDPNP GHIAAVYENL AKEDSKDGFT IGIVDDVTNT SLEVHQDIDA TPEGTTACKF WGLGSDGTVG ANKSAIKIIG DHTDMYAQGY FFYDSKKSGG ITVSHLRFGK KAIKSPYLIN KADFVSCSNQ SYVHKYNVLD GLKPGSTFLL NTIWTPEELE EKLPGSYKRF LANNNIKFYT INAVGIAQEI GLGGRINMIM QSAFFKLANI IPVEDAVKYL KDAVVTSYGK KGQKVVDMNN AAIDKGVESI VKIDIPESWK DAKDEEVENN HKMTEFVKNI VIPMNRQEGD SLPVSTFMGM EDGTFEAGTA AYEKRGIAVN VPEWVPEKCI QCNQCAYVCP HAAIRPFLLN DAEKAAAPES MKLVPAKALK TEEPLSFSIG VTPLDCTGCG NCAQVCPAPG KALIMKPQES QHDQMEAWDY AVEEVSAKKN PMNKNTVKGS QFEQPLLEFS GACAGCGETP YAKLITQLFG DRMMIANATG CSSIWGGSAP STPYTINHKG HGPAWANSLF EDNAEFGLGM FLGVKAIRER IANNLKALLE EGVNDDVKVV VEDWLANMNN GEGTRDRAEK LEATLATVNS ELAKKVLDEK DYFVKRSQWI FGGDGWAYDI GYGGVDHVLA SGEDVNIFVF DTEVYSNTGG QSSKSTPTAA IAKFAASGKK TKKKDLGMMA MSYGYVYVAQ VNMGADKNQT LKAIAEAEAY QGPSLIIGYA PCINHGIKIG MGNSQQEAKR ATDCGYWAMY RYNPQLKGTK NPFALDSKEP KADFKEFLMG EVRYASLAKA FPEAADALFE KTYNDAMERL AGYKKLAEQE Profile: ·····T·N·N T······D·· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······DY·· ·S·······K ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· K········· ·S···D···· ·········· ··········
query > profilegap>D9gap>K10gap>N11gap>D17T6>T23D8>N25N10>N27T11>T28Y18>D34D287>D45Y288>Y46N292>S49K300>K57E1131>K68P1142>S80D1146>D84
IPR001329 — Glycoside hydrolase family 56, bee venom hyaluronidase (domain 11–24)
Cross-ref: InterPro: IPR001329
GO: GO:0004415 hyalurononglucosaminidase activityGO:0006952 defense response
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MRKMKTMDGN TAAAHISYAF TEVAAIYPIT PSSPMAEHVD EWVAQGRKNI FGQPVQVMEM QSEAGAAGAV HGSLQAGALT STYTASQGLL LMIPNMYKIA GEMLPGVFHV SARALATSAL NIFGDHQDVM AARQTGFAML AEGSVQEVMD LSAVAHLTAI KSRIPFVNFF DGFRTSHEIQ KIEVLEYDEL ANLVDWDSVE AFRARALNPN HPVTRGTAQN ADIYFQEREA VNKFYQAVPD IVEGYMAEIT KLTGREYHCF DYYGAPDADR IIIAMGSVTD VCEETVDYLN ANGQKVGVVK VRLYRPFSIE KLMKAIPASA KKIAVLDRTK EPGSAGEPLY LDVKNAFYGK ENAPVIVGGR FGLGSKDPNP GHIAAVYENL AKEDSKDGFT IGIVDDVTNT SLEVHQDIDA TPEGTTACKF WGLGSDGTVG ANKSAIKIIG DHTDMYAQGY FFYDSKKSGG ITVSHLRFGK KAIKSPYLIN KADFVSCSNQ SYVHKYNVLD GLKPGSTFLL NTIWTPEELE EKLPGSYKRF LANNNIKFYT INAVGIAQEI GLGGRINMIM QSAFFKLANI IPVEDAVKYL KDAVVTSYGK KGQKVVDMNN AAIDKGVESI VKIDIPESWK DAKDEEVENN HKMTEFVKNI VIPMNRQEGD SLPVSTFMGM EDGTFEAGTA AYEKRGIAVN VPEWVPEKCI QCNQCAYVCP HAAIRPFLLN DAEKAAAPES MKLVPAKALK TEEPLSFSIG VTPLDCTGCG NCAQVCPAPG KALIMKPQES QHDQMEAWDY AVEEVSAKKN PMNKNTVKGS QFEQPLLEFS GACAGCGETP YAKLITQLFG DRMMIANATG CSSIWGGSAP STPYTINHKG HGPAWANSLF EDNAEFGLGM FLGVKAIRER IANNLKALLE EGVNDDVKVV VEDWLANMNN GEGTRDRAEK LEATLATVNS ELAKKVLDEK DYFVKRSQWI FGGDGWAYDI GYGGVDHVLA SGEDVNIFVF DTEVYSNTGG QSSKSTPTAA IAKFAASGKK TKKKDLGMMA MSYGYVYVAQ VNMGADKNQT LKAIAEAEAY QGPSLIIGYA PCINHGIKIG MGNSQQEAKR ATDCGYWAMY RYNPQLKGTK NPFALDSKEP KADFKEFLMG EVRYASLAKA FPEAADALFE KTYNDAMERL AGYKKLAEQE Profile: ·········· ··CH······ ·E········ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··········
query > profileA13>C3A14>H4E22>E12
IPR006101 — Glycoside hydrolase, family 2 (domain 283–298)
Cross-ref: InterPro: IPR006101
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MRKMKTMDGN TAAAHISYAF TEVAAIYPIT PSSPMAEHVD EWVAQGRKNI FGQPVQVMEM QSEAGAAGAV HGSLQAGALT STYTASQGLL LMIPNMYKIA GEMLPGVFHV SARALATSAL NIFGDHQDVM AARQTGFAML AEGSVQEVMD LSAVAHLTAI KSRIPFVNFF DGFRTSHEIQ KIEVLEYDEL ANLVDWDSVE AFRARALNPN HPVTRGTAQN ADIYFQEREA VNKFYQAVPD IVEGYMAEIT KLTGREYHCF DYYGAPDADR IIIAMGSVTD VCEETVDYLN ANGQKVGVVK VRLYRPFSIE KLMKAIPASA KKIAVLDRTK EPGSAGEPLY LDVKNAFYGK ENAPVIVGGR FGLGSKDPNP GHIAAVYENL AKEDSKDGFT IGIVDDVTNT SLEVHQDIDA TPEGTTACKF WGLGSDGTVG ANKSAIKIIG DHTDMYAQGY FFYDSKKSGG ITVSHLRFGK KAIKSPYLIN KADFVSCSNQ SYVHKYNVLD GLKPGSTFLL NTIWTPEELE EKLPGSYKRF LANNNIKFYT INAVGIAQEI GLGGRINMIM QSAFFKLANI IPVEDAVKYL KDAVVTSYGK KGQKVVDMNN AAIDKGVESI VKIDIPESWK DAKDEEVENN HKMTEFVKNI VIPMNRQEGD SLPVSTFMGM EDGTFEAGTA AYEKRGIAVN VPEWVPEKCI QCNQCAYVCP HAAIRPFLLN DAEKAAAPES MKLVPAKALK TEEPLSFSIG VTPLDCTGCG NCAQVCPAPG KALIMKPQES QHDQMEAWDY AVEEVSAKKN PMNKNTVKGS QFEQPLLEFS GACAGCGETP YAKLITQLFG DRMMIANATG CSSIWGGSAP STPYTINHKG HGPAWANSLF EDNAEFGLGM FLGVKAIRER IANNLKALLE EGVNDDVKVV VEDWLANMNN GEGTRDRAEK LEATLATVNS ELAKKVLDEK DYFVKRSQWI FGGDGWAYDI GYGGVDHVLA SGEDVNIFVF DTEVYSNTGG QSSKSTPTAA IAKFAASGKK TKKKDLGMMA MSYGYVYVAQ VNMGADKNQT LKAIAEAEAY QGPSLIIGYA PCINHGIKIG MGNSQQEAKR ATDCGYWAMY RYNPQLKGTK NPFALDSKEP KADFKEFLMG EVRYASLAKA FPEAADALFE KTYNDAMERL AGYKKLAEQE Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·N·····Y·· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··········
query > profileN292>N10V298>Y16
PF03633 — Glycosyl hydrolase family 65, C-terminal domain (domain 1–998)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 Query: MRKMKTMDGN TAAAHISYAF TEVAAIYPIT PSSPMAEHVD EWVAQGRKNI FGQPVQVMEM QSEAGAAGAV HGSLQAGALT STYTASQGLL LMIPNMYKIA GEMLPGVFHV SARALATSAL NIFGDHQDVM AARQTGFAML AEGSVQEVMD LSAVAHLTAI KSRIPFVNFF DGFRTSHEIQ KIEVLEYDEL ANLVDWDSVE AFRARALNPN HPVTRGTAQN ADIYFQEREA VNKFYQAVPD IVEGYMAEIT KLTGREYHCF DYYGAPDADR IIIAMGSVTD VCEETVDYLN ANGQKVGVVK VRLYRPFSIE KLMKAIPASA KKIAVLDRTK EPGSAGEPLY LDVKNAFYGK ENAPVIVGGR FGLGSKDPNP GHIAAVYENL AKEDSKDGFT IGIVDDVTNT SLEVHQDIDA TPEGTTACKF WGLGSDGTVG ANKSAIKIIG DHTDMYAQGY FFYDSKKSGG ITVSHLRFGK KAIKSPYLIN KADFVSCSNQ SYVHKYNVLD GLKPGSTFLL NTIWTPEELE EKLPGSYKRF LANNNIKFYT INAVGIAQEI GLGGRINMIM QSAFFKLANI IPVEDAVKYL KDAVVTSYGK KGQKVVDMNN AAIDKGVESI VKIDIPESWK DAKDEEVENN HKMTEFVKNI VIPMNRQEGD SLPVSTFMGM EDGTFEAGTA AYEKRGIAVN VPEWVPEKCI QCNQCAYVCP HAAIRPFLLN DAEKAAAPES MKLVPAKALK TEEPLSFSIG VTPLDCTGCG NCAQVCPAPG KALIMKPQES QHDQMEAWDY AVEEVSAKKN PMNKNTVKGS QFEQPLLEFS GACAGCGETP YAKLITQLFG DRMMIANATG CSSIWGGSAP STPYTINHKG HGPAWANSLF EDNAEFGLGM FLGVKAIRER IANNLKALLE EGVNDDVKVV VEDWLANMNN GEGTRDRAEK LEATLATVNS ELAKKVLDEK DYFVKRSQWI FGGDGWAYDI GYGGVDHVLA SGEDVNIFVF DTEVYSNTGG QSSKSTPTAA IAKFAASGKK TKKKDLGMMA MSYGYVYVAQ VNMGADKNQT LKAIAEAEAY QGPSLIIGYA PCINHGIKIG MGNSQQEAKR ATDCGYWAMY RYNPQLKGTK NPFALDSKEP KADFKEFLMG EVRYASLAKA FPEAADALFE KTYNDAMERL AGYKKLAEQE Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··········
query > profile
↑ Top





v1.01 @copyright 2026 UCLA